免疫性血小板输血折射性:从机制到治疗方法的当前见解
Xiaoyu Chen1, Yuhong Zhao1, Yan Lv1
1Department of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Platelets
|February 5, 2024
概括
血小板输血折射性 (PTR) 是一个严重的问题. 本综述探讨了免疫系统调节和新型治疗方法,以对抗非免疫接种并改善血小板输血结果.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 输血医学 输血医学
背景情况:
- 血小板输血折射性 (PTR) 尽管在血小板生产和储存方面取得了进展,但存在重大临床挑战.
- 通过FcγR或补充通路的抗体介导的血小板破坏是PTR的主要原因,有其他清除机制的新兴证据.
- 目前的PTR管理依赖于兼容的血小板选择,由于捐赠池的限制和复杂的测试,这是资源密集的.
研究的目的:
- 阐明免疫系统在异性血小板激活和清除中的作用.
- 审查目前管理PTR和免疫接种的策略.
- 探索免疫性PTR和预防非免疫化的新疗法方法.
主要方法:
- 综合文献综述,重点关注血小板清除的免疫机制.
- 对研究抗体介导和其他血小板破坏途径的研究进行分析.
- 对PTR和免疫接种的治疗干预措施的研究综合.
主要成果:
- 免疫系统通过抗体依赖和独立的机制显著调节异构血小板存活率.
- 目前对PTR的治疗方法受限于对相容的捐赠者和专门测试的需求.
- 新兴研究突出了PTR和合免疫的潜在新疗法目标.
结论:
- 了解免疫系统调节对于开发有效的PTR疗法至关重要.
- 需要新的治疗策略来克服当前PTR管理的局限性.
- 准其他免疫路径为改善输血疗效提供了一个有希望的途径.
相关概念视频
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
525
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
525
Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Introduction to Hemostasis
7.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.8K


